Safe Implant Technology ApS: Financial statements 2024
CVR: 38969153
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Safe Implant Technology ApS (CVR 38969153) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -58,021 and a net result of DKK -724,511 compared with DKK -194,735 the year before. Equity in the 2024 report amounted to DKK -892,403. The company had 2 employees in the financial year.
- Gross Profit
- DKK -58,021
- Profit/Loss
- DKK -724,511
- Equity
- DKK -892,403
- Total Assets
- DKK 1,239,477
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -58 t. | -725 t. | -892 t. | 2 |
| 2023 | - | -195 t. | -195 t. | -168 t. | 0 |
| 2022 | - | -6 t. | -7 t. | 27 t. | 0 |
| 2021 | - | -7 t. | -7 t. | 34 t. | 0 |
| 2020 | - | -3 t. | -3 t. | 41 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Safe Implant Technology ApS has published its annual report for 2023. Gross profit came to DKK -194,943, and the net result was DKK -194,735.
About Safe Implant Technology ApS
Safe Implant Technology ApS is a Danish company of the type Anpartsselskab based in Fårevejle, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Henrik Nakskov. The board consists of Søren Luplau-Pagh (chair), Gorm Danscher, Henrik Nakskov and Lone Damgaard Horup. The company is owned by BERLOCK ApS and Devopharma ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 756,423 and a net result of DKK -53,855 compared with DKK -724,511 the year before. Equity in the 2025 report amounted to DKK -946,258.